Six (or More) Drugs in Search of a Mechanism: DNA Methyltransferase and Histone Deacetylase Inhibitors in the Treatment of Myelodysplastic Syndromes

Author： Gore Steven D.  

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.4, Iss.1, 2006-01, pp. : 83-90

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Utility of DNA Methyltransferase Inhibitors for the Treatment of Myelodysplastic Syndromes

By  

Current Pharmaceutical Design, Vol. 18, Iss. 22, 2012-07 ,pp. : 3190-3197

Bentham Science Publishers

Access to resources Recommend Favorite

Combining DNA methyltransferase and histone deacetylase inhibition to treat acute myeloid leukemia/myelodysplastic syndrome: Achievements and challenges

By Lübbert Michael   Kuendgen Andrea  

Cancer, Vol. 121, Iss. 4, 2015-02 ,pp. : 498-501

Blackwell Publishing

Access to resources Recommend Favorite

Towards Histone Deacetylase Inhibitors as New Antimalarial Drugs

By  

Current Pharmaceutical Design, Vol. 18, Iss. 24, 2012-08 ,pp. : 3467-3479

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies

By  

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 6, 2011-06 ,pp. : 519-527

Bentham Science Publishers

Access to resources Recommend Favorite

The Synergistic Effects of DNA-Targeted Chemotherapeutics and Histone Deacetylase Inhibitors As Therapeutic Strategies for Cancer Treatment

By  

Current Medicinal Chemistry, Vol. 19, Iss. 25, 2012-09 ,pp. : 4218-4238

Bentham Science Publishers

Access to resources Recommend Favorite